6 completed, 3 unknown. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Unknown 3 |
| Phase 3 | 1 | Completed 1 |
Follow Tuberculin: new trials by email Literature Review of Tuberculin trials Research Report on Tuberculin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function Q10 - Non-Alcoholic Fatty Liver Disease | Phase 2 | Unknown | Attikon Hospital | 60 | 2023-04-01 | 2023-07-12 |
| Impact Of Intralesional Tuberculin Ppd Injection On Anogenital protein purified derivative - Human Papilloma Virus, Infections | Phase 2 | Completed | Universitas Padjadjaran | 24 | 2022-04-01 | 2025-07-18 |
| Triple Antigen vs Monoantigen Immunotherapy for Warts Intralesional antigen immunotherapy - Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts | Phase 2 / Phase 3 | Completed | Zagazig University | 160 | 2020-11-20 | 2022-02-24 |
| Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative, 5μg/ml ESAT6-CFP10 and tuberculin purified protein derivative, 10μg/ml ESAT6-CFP10 and tuberculin purified protein derivative - Tuberculosis | Phase 2 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 144 | 2014-02-01 | 2015-04-09 |
| Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2) To compare new PPD to reference standard material, Reference standard - Tuberculosis Identification. | Phase 2 | Unknown | JHP Pharmaceuticals LLC | 90 | 2013-02-01 | 2013-02-25 |
| Equivalence Study of Specificity of PPD Aplisol@ PPD material, Reference Standard - Tuberculosis Infection | Phase 2 | Unknown | JHP Pharmaceuticals LLC | 152 | 2013-02-01 | 2013-02-25 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG C-Tb, 2 TU Tuberculin PPD RT 23 SSI - Tuberculosis | Phase 2 | Completed | Statens Serum Institut | 151 | 2011-04-01 | 2013-01-21 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) C-Tb, 2 TU Tuberculin PPD RT 23 SSI - Tuberculosis | Phase 2 | Completed | Statens Serum Institut | 253 | 2011-04-01 | 2015-04-17 |
| Leprosy Skin Test Antigens Trial Tuberculin, Purified Protein Derivative, MLSA-LAM, MLCwA - Leprosy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 260 | 2002-04-01 | 2014-12-24 |
Tuberculosis (4) · Infections (1) · Latent Tuberculosis (1) · Leprosy (1) · Non-alcoholic Fatty Liver Disease (1) · Warts (1)
JHP Pharmaceuticals LLC (2) · Statens Serum Institut (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Attikon Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universitas Padjadjaran (1) · Zagazig University (1)
United States (2) · Egypt (1) · Greece (1) · Indonesia (1) · Nepal (1) · South Africa (1) · United Kingdom (1)
Birgit Thierry-Carstensen (2) · David JM Lewis, MD (1) · Keertan Dheda, MD (1) · Qi Wu, Master (1) · Shuihua Lu, Bachelor (1)
PMID 23691171, PMID 24874401, PMID 26677940, PMID 38987784
2009 (1)